At Novo Nordisk, we don’t wait for change. We drive it.
Nothing reflects this pioneering spirit more than the advancements that we’re making in oral therapy, and the people who are making it happen. We’re united on our mission to create the next generation of innovative oral products. From discovery to production, and every step along the way, our forward-thinking teams of scientists, engineers, and data specialists, are pushing the boundaries of possibility to take us all forward.
Our work is taking centre stage at Novo Nordisk, which means we’re growing. Fast. Join us on our journey.
The work we do within oral therapies represents the future direction of our company, as we’re applying the innovations made within this space across the different therapeutic areas that we operate in. Our work has - with our pioneering GLP-1 RA oral formulation for type 2 diabetes - and will continue to have a huge impact on the lives of millions of patients around the world today. Above this, though, our achievements in this space will be seen as landmarks in the treatment of chronic diseases for years to come.
The work we do within the oral therapies spans from research and development all the way through production, and is carried out by three business units: Oral Formulation Research, Oral Protein Formulation and finally Oral Finished Products.
Step 1: Discovery: The ideas and new formulation
concepts are developed by our colleagues in Oral Formulation
Step 2: Develop: The analytical processes are further matured in Oral Protein Formulation and tested in clinical trials
Step 3: Deploy: Finally, the processes are upscaled and validated to accommodate commercial supply in Oral Finished Products
We’re constantly on the lookout for talented and ambitious colleagues to join us across the value chain. Are you interested in being part of this journey? Read below to learn about the different business units and how you can get involved